General purpose technologies (GPTs) provide fundamental breakthroughs that transform industries and provide a platform for increased productivity. While a large theoretical literature describes GPT characteristics there has been little empirical work that measures the attributes of GPTs. Our analysis focuses on patents associated with the Cohen-Boyer rDNA patents, a credible GPT candidate. We empirically test our predictions about technological complementarity, applicability and discontinuity against a control group of patents with similar origins.
Introduction
The introduction, diffusion, and adaptation of new technologies provide the basis for economic growth. Certain discoveries, called general purpose technologies (GPTs), provide fundamental breakthroughs that transform industrial activity and provide a platform for increased productivity throughout the economy. Historical examples such as the steam engine, electricity, and computers share attributes that are particularly salient for long-running economic growth (Helpman, 1998; Crafts, 2004; Rosenberg and Trajtenberg, 2004; Lipsey et al., 2005) . GPTs represent new knowledge that is complementary with existing technologies and applicable to a broad 2. Defining GPT Academics, since Schumpeter (1911) , have explored the origins of new industries and the impacts of technological breakthroughs and entrepreneurial activities on economic growth. Schumpeter identified long cycles of economic growth attributable to basic inventions that, when their economic potential was revealed, created surges of investment. The result was a temporal burst of economic growth as the invention diffused widely across the economy. These "gales of creative destruction," as Schumpeter labeled them, alter technological and economic advantages both within and between countries. In Schumpeter's conceptualization, technological change is endogenously determined and is the most important factor for creating economic growth.
The concept that major revolutionary discoveries drive economic growth has persisted in a variety of conceptualizations. Nelson and Winter (1982: 257) called technological regimes "the frontier of achievable capabilities along a complementary set of research trajectories" and the primary drivers of economic growth. Freeman and Perez (1998) defined platforms that create opportunity for profitable investment in a large set of innovations, called carrier branches.
Scholars expanding these ideas more recently have focused on the concept of GPTs (Helpman, 1998; Lipsey et al., 2005) . The criteria for defining a GPT are not yet standardized. According to Lipsey et al. (2005: 96) , a GPT is "a single technology, recognizable as such over its whole lifetime that initially has much scope for improvement and eventually comes to be widely used, to have many uses, and to have many spillover effects." For example, Lipsey et al. (2005: 99) have argued that gunpowder is not a GPT because, despite its tremendous social and economic impact, it had limited adaptability across industrial sectors. Meanwhile, computers and microprocessors could be considered a GPT because they have been used widely and in a variety of ways (Lipsey et al., 2005: 94) . Moser and Nicholas (2004) embraced the four characteristics enumerated by Lipsey et al. (1998) : a wide scope for improvement and elaboration; applicability across a broad range of uses; potential for use in a wide variety of products and processes; and strong complementarities with existing or potential new technologies. Their empirical results concluded that electricity could not be considered a GPT, a finding that contradicts historical productivity growth (David, 1990) and raises questions about the methodology (Lipsey et al., 2005: 108, 9) . Alternatively, Hall and Trajtenberg (2004) relied on the criteria provided by Helpman and Trajtenberg (1998a) : pervasiveness in terms of use across multiple sectors of the economy; continuous related technical advances; and complementarity in terms of investment in downstream sectors. Hall and Trajtenberg used patent data to define four operational measures of a GPT: number of patent citations from outside the original patent class; a pattern of cumulative innovation within its technology area; a burst of activity as complementary goods are developed; and longer than average citation patterns reflecting the length of time required for a GPT to pervade the economy. They used these criteria to examine all US patents from 1967 to 1999 and found that only a small number of patents were credible candidates for GPTs. This may reflect several artifacts. First, while radical breakthrough technologies often have long time lags, it is not clear exactly how much time should be allowed for the complementary expertise associated with a GPT to develop. Certainly, the length of time required to capitalize on a GPT will be a function of factors such as general economic conditions, industry structure, and firm strategy. Second, a GPT may be the product of sets of complementary patents rather than a single patent. A patent family that encompasses different applications may qualify as a GPT although no single patent created sufficient impact. Finally, because technology class is a categorical assignment, the distribution of citations among technology classes is heterogeneous (Hall et al., 2001: 12, 13 ). Analyses of the universe of patents should account for this heterogeneity with fixed effects or by making comparisons within a technology class.
As there is limited agreement about the measurable characteristics of a GPT, the next section endeavors to define a consensus set of characteristics that will guide our empirical analysis. The literature suggests three GPT characteristics that might be measured empirically with patent data: complementarity, applicability, and discontinuity.
Technological complementarity
There is general agreement that a GPT can be integrated with a wide range of industrial applications in order to realize productivity gains (Helpman, 1998; Rosenberg and Trajtenberg, 2004; Lipsey et al., 2005) . GPTs are radical innovations that motivate subsequent incremental innovations in a broad array of established industrial sectors. Thus a GPT will be punctuated by a follow-on set of more incremental innovation that adapts the breakthrough technologies across a range of existing industrial sectors (Bresnahan and Gambardella, 1998) . Specifically, we would expect other economic sectors to conduct R&D in order to combine the GPT invention with sector-specific expertise, thus creating new, complementary inventions leading to economic growth (Helpman and Trajtenberg, 1998b) .
Technologies are complementary when two or more technologies are combined to create a novel and unique new technology, or "when the decisions of the initiating agents with respect to their own technologies affect the value of the receiving agents' existing technologies and/or their opportunities for making further technological changes" Lipsey, 2002: 1310) . Thus, we would expect to see a GPT integrated into follow-on inventions across a broader array of industries. This suggests the following prediction:
Hypothesis 1: Follow-on inventions using GPT will be combined with complementary applications in a broader number of technology sectors when compared to other inventions.
We use the term technological complementarity to indicate a GPT's potential to induce R&D investment in a broad number of downstream industries. Specifically, we would expect a GPT to be cited in combination with prior art from a larger variety of industrial sectors in first-generation patents when compared to the control patents.
Technological applicability
The second generally accepted characteristic of a GPT is its ability to be incorporated into a wide variety of different industrial applications (Bresnahan and Gambardella, 1998) . Lipsey et al. (2005) argue that this characteristic is often discussed in one of two ways: either as vertical applicability, in which the GPT is used widely in the subsectors of one industry sector, or as horizontal applicability, in which the GPT is applicable across a variety of diverse industry sectors. Bresnahan and Gambardella (1998) emphasize that horizontal usage is the key attribute if economic growth is to be realized, arguing that a wide scope of applicability is what makes a technology general, in that it can be used for a variety of purposes in different industries. These authors argue that "the extent of the market for a GPT is not only the volume of production in the one sector that applied it, but also the number of distinct application sectors that apply it" (p. 255). A GPT provides knowledge that can be incorporated into subsequent follow-on inventions in diverse industries in order to realize its economic growth potential. Thus, Hypothesis 2: Follow-on inventions built on a GPT will be applied to a wider range of industries than other inventions Specifically, inventions that cite a GPT are likely to be assigned to a wider range of industry sectors than those citing incremental innovations. This is similar to the concepts of "patent scope" as introduced by Lerner (1994) and "generality" as introduced by Hall et al. (2001) to measure the technology diversity of follow-on inventions. Following Hall and Trajtenberg (2004) , we developed a generality measure to capture the broad application of a GPT in subsequent second-generation inventions. The generality measure is the proportion of total forward citations accrued in patent classes outside the GPT's original patent class.
Technological discontinuity
Finally, a GPT introduces discontinuity in the sense that it represents a radical break with existing practice (Helpman, 1998; Rosenberg and Trajtenberg, 2004; Lipsey et al. 2005) . In contrast to incremental innovations that provide enhancements or improvements to existing means of production, GPTs represent radical departures from existing knowledge. There are two relevant empirical aspects of this discontinuity. The first relates to the geographic locus of inventive activity and the second relates to the time lag associated with technology diffusion.
The geographic extent of knowledge spillovers and the importance of proximity is expected to be different between radical and incremental technologies. It may be relatively easy for incremental discoveries to diffuse widely: for instance, an expert trained in one field could read about an incremental discovery in another field and incorporate it into his or her own work. However, as a GPT is new and relatively unfamiliar to researchers trained with existing technology, the technological significance, and mechanics of an innovation would be more difficult to communicate. Face-to-face conversations would become critical to the exchange of meaningful ideas, to ascertaining the opportunities a new technology presents, and to capturing a tacit understanding of how to advance the technology (Audrestch and Feldman, 1996) . Thus, we would expect to see more complementary inventive activities initially in geographic proximity to inventors familiar with that GPT:
Hypothesis 3: Relative to an incremental technology, a GPT will spur greater technological complementarity and applicability in the geographic area where it originated.
We believe that innovation has a strong local component (Feldman and Kogler, 2010) . As the GPT matures it becomes codified and diffuses more rapidly. However, the ways a GPT is refined and adapted is expected to have a decided geographic component as knowledge is recombined with existing expertise in a region, leading to geographic concentrations of specific industries and applications. Co-location of groups of inventors with an existing expertise is expected to yield differentiated adaptation of the discovery. Over time, as new discoveries are incorporated into existing expertise, we would expect technological trajectories to develop that reflect unique regional expertise.
In conclusion, the GPT literature posits the importance of three associated empirical regularities: technological complementarity, technological applicability, and technological discontinuity. The next section will consider one example widely classified as a GPT: the Cohen-Boyer patents.
Overview of the Cohen-Boyer's rDNA technology
On December 2, 1980, Stanford University was granted a patent for rDNA methods developed by Dr Stanley Cohen of Stanford and Dr Herbert Boyer of the University of California, San Francisco. The patent, entitled Process for Producing Biologically Functional Chimeras (US 4237224), and its claims indicate that the Cohen-Boyer method for recombining genetic material represented a fundamental scientific discovery. The Cohen-Boyer patent application claimed both the process of making rDNA and any products enabled by that process.
The Cohen-Boyer patent application was filed in 1974 and was subject to 6 years of debate and three continuations until it was granted in 1980. Two factors contributed to the delay. First, university patents were rather unusual at the time and ownership of discoveries funded under federal grants was not automatically assigned to universities. It is notable that these patents were part of the debate that culminated in the December 12, 1980, passage of P.L. 96-517, The Patent and Trademark Law Amendments Act, commonly known as the Bayh-Dole Act (Fredrickson, 2001 ). Second, rDNA was highly controversial because it unleashed the potential to genetically modify organisms. The scientific community agreed to a voluntary moratorium on rDNA research until its safety could be investigated and established (Smith Hughes, 2001 Boyer patents referred to "process" and "product" patents, the "product" claims cover compositions of matter (rDNA plasmids), which were then used to make proteins and are a basic component of the production method. Thus, although three patents were granted, Stanford University licensed them as a single technology (Feldman et al., 2008) . Ruttan (1999) has argued that biotechnology will be the most important GPT of the first half of the 21st century. In addition to rDNA, two other techniques associated with biotech are fermentation and monoclonal antibodies. Fermentation is an established technique with a long history of incremental innovation. Monoclonal antibodies, discovered by Georges Kohler, Cesar Milstein, and Niels Kaj Jerne in 1975, were not patented.
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As a GPT, we would expect to find both a spatial and temporal discontinuity, which can be examined by considering the time lag and geographical concentration of follow-on inventive activities. The Cohen-Boyer technology has been cited 362 times. Patents that cite Cohen-Boyer are concentrated in California, specifically around the San Francisco Bay area where Cohen and Boyer worked. The industry 1 A prokaryotic cell is one without a contained nucleus. The prokaryotic patent is US 4468464, issued on August 28, 1984. 2 A eukaryotic cell has a contained nucleus. The eukaryotic patent is US 4740470, issued on April 26, 1988. 3 Another potential candidate for a GPT is the technique for making polymerase chain reactions (PCR). This foundational piece of biotechnology intellectual property is contained in two US patents, 4,683,195 and 4,683,202, filed in 1985 and issued to Cetus Corporation on July 28, 1987. Invented by Kary B. Mullis and developed by Cetus, the technology was sold to Roche for $300m in 1991 and aggressively licensed. The patents had received 2228 citations as of February 6, 2011. We thank an anonymous referee for pointing this out.
Empirical test for GTPs developed on the East Coast as well, but there were notably fewer patent citations there. These results are hardly conclusive given that we lack data on the universe of inventors who might have potentially cited the patent. Nevertheless, the pronounced concentration of inventive activity in the Bay area supports the notion that the technology community building on the Cohen-Boyer patents was geographically concentrated.
To identify the technology sectors where inventive activity took place, we constructed location quotients using the location of inventions citing the Cohen-Boyer patents by industry sectors based on the Derwent World Patent Index (DWPI) in Table 1 . 4 For each of the most prevalent sub-technologies associated with biotechnology, we calculated the proportion of patents in the region that cited Cohen-Boyer, by sector, and divided it by the proportion of patents that cited Cohen-Boyer in the sector. If a region's technology had a location quotient 41, the proportion of technology patents citing Cohen-Boyer in that sector was greater than the national average. Including the San Francisco Bay area, where rDNA technology originated, there are 17 unique metropolitan statistical areas (MSAs) with location quotients 41. For example, the Boston area applied Cohen-Boyer technology to scientific instruments (location quotient ¼ 2.06), St Louis innovations concentrated around plant genetics (location quotient ¼ 13.12), and Houston inventors were most active in animal care (location quotient ¼ 26.67). The San Francisco area had the largest number of technology classes with a location quotient higher than one. Moreover, the number of classes with a location quotient 41, indicating specialization, increased over time in San Francisco. The well-represented technology classes in the San Francisco area in the first period (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) were natural products and polymers, and fermentation. In the second period (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) , concentrated sectors emerged in diagnosis, surgery, other foodstuffs, and treatment.
The fact that Cohen-Boyer's rDNA technology was incorporated in different applications in different locations suggests that existing capability within a place was a factor in adapting the new technology. This may be the basis for regional technological specialization as GPTs are incorporated and adapted to existing expertise. The table also indicates that activity in the San Francisco area benefited from spatial proximity-that locating in the place where Cohen-Boyer's rDNA technology originated encouraged its application to a greater number of technology classes.
Next, we addressed the lag of follow-on inventive activities. Hall and Trajtenberg (2004) found that citations to GPT had a longer time lag than the average patent. Figure 1 provides the timing of forward citations to Cohen-Boyer. There are two peaks in forward citations. The first peak was 4 years after the patent was granted, and the second peak was from Years 17 to 19. The second peak of forward citations 4 Technology sectors by Derwent World Patent Index system is used rather than Standard Industrial Classification (SIC) in order to cross check the significance of the analysis. Empirical test for GTPs was due largely to patents for nucleic acid tests, used as diagnostics for a variety of human diseases. Given that the Cohen-Boyer invention took 6 years to issue from the date of its original application, the citation time lag was 23-25 years after the date of discovery and longer than the 17 year duration of the patent. For comparison, Hall and Trajtenberg, (2004) and Hall et al. (2001) found that, on average, patent citations peak at 6 years and argue that a technology becomes obsolete after 6 years. The Cohen-Boyer technology was so radical that it had significant impact on the follow-up inventions for three times longer than citation lag of the average invention.
Data and methodology
To test the hypothesis that the Cohen-Boyer technology is a GPT, we constructed a novel data set of patents that cited the Cohen-Boyer patents and estimated their characteristics against a group of patents that cited a control group of similar patents. Initially, we used five criteria to construct our control group: technology class, the year a patent was issued, the numbers of backward and forward citations, and assignee type. A control group should also represent classes developed around similar technologies and in a similar time period. Patel (2003) suggests that the patent classes of genetic engineering (424), biosensors (514), and biological materials for therapeutic applications (530) or with genetic applications (536) were similar to the Cohen-Boyer rDNA discovery. From these, we selected patents issued in 1976-1980. There were 5725 US patents granted in the four control patent groups in 1976-1980. From these, we selected patents with no domestic backward citation and at least 50 forward citations. Patents with no backward patent citations do not reference prior patent art and are expected to be more radical in terms of their technological contribution (Jaffe et al., 1993) . Forward citations are another measure of a patent's importance: Hall and Trajtenberg (2004) estimate that only 0.01% of US patents receive more than 100 forward citations. Among applications filed in 1976-1980, the average number of forward citations was less than seven (Hall et al., 2001 ). In our 5725 biotechnology patents applied for between 1976 and 1980, only five patents received more than 50 forward citations, and no other biomedical patent was cited as often as the Cohen-Boyer technology. Finally, Cohen-Boyer was a university patent, and university patents are generally more basic in nature and more likely to become a GPT (Mokyr, 1990) . Therefore, our fifth criterion for control patents was assignment to a university.
Two patents that satisfied all five criteria for the control were US4164559, assigned to Cornell University, and US4201770, assigned to Ohio State University. These patents had 50 and 55 unique forward citations, respectively, excluding reissued patents. The product technologies they covered are summarized in Table 2 . We also included a patent granted to Stanford University (US394907) that covers a process technology in the field of biotechnology. This patent is included because of the 127 forward citations received even though it referenced prior art.
5 This patent provides an additional control for the effect of an invention originating at Stanford University. The three patents in our control group were widely cited. The average forward citation for the 5725 patents in biotechnology is 5.7. Hence, the effect of applicability and complementarity of the Cohen-Boyer's technology is conservatively analyzed, compared to the situation where we included all the patents in biotechnology as the control group.
Our unit of observation is second-generation patents that cite either the CohenBoyer patents or the control group patents: both the Cohen-Boyer and control group serve as prior art
We have a total of 594 observations: 362 observations that cite the Cohen-Boyer technology, and 232 observations that cite the three control patents.
We examined all prior art included with each second-generation patent to determine the technological origin for each new invention. The fact that these patents were combined with our focal patents suggests they provide complementary 
Dependent variables
To test Hypothesis 1, technological complementarity, we constructed a variable that measures the number of unique industry sectors associated with the patents that are combined with the primary patent, with Cohen-Boyer or the controls, to create a new follow-up invention, patent i in year j. These patents are the first-generation inventions that are cited by the second-generation patents. We constructed this variable by matching each citing, or first-generation, patent to the Standard Industrial Classification (SIC)-concordance table provided by the USPTO. There Note that we excluded reissued patents and patents in the same patent family from the count of unique patents because the original patents were already counted.
are over 100,000 subclasses and each application is evaluated to assess novelty and the relationship to prior art. Patent examiners assign an application to one or more subclasses. Lerner (1994: 320, 1) notes that examiners have incentive to classify patents carefully because the patent becomes prior art for subsequent searches. Also, to ensure accuracy and maintain consistency, each classification is subject to review and oversight. There can be multiple patent classes associated with each patent, and hence, a patent can be associated with multiple industry sectors. Thus, when a patent had a class that matched at least one industry sector, we counted that industry as associated with the patent. We only counted those industries that were different from the primary patent. To test Hypothesis 2, technological applicability, we used the procedure outlined above to construct a variable that measures the number of unique industries associated with each second-generation patent that cited either Cohen-Boyer or the control patents, using the USPTO patent class-SIC concordance table to assign patent classes to industry sectors.
Independent variables
To test for technological discontinuity, Hypothesis 3, the locations of inventors are included. Following the logic that patent citations are more likely to be in the same metropolitan area, (Jaffe et al., 1993) , we constructed a dummy variable equal to one if all the inventors listed on a patent had an address in the San Francisco Bay MSA, the location of Stanley Cohen (Stanford University), and Herbert Boyer (University of California, San Francisco) while developing their rDNA discovery.
A discovery is expected to incorporate more unique types of knowledge when more inventors are involved. We controlled for the number of inventors by counting the number of inventors listed on the patent. Similarly, the number of assignees may also be important, as novel technologies can be developed by interaction among different organizations (Rosenkopf and Nerker, 2001) We also used the number of backward citations and the number of claims to control for the effect of the absolute number of backward citations and the number of claims on the number of different ways a technology can be used or applied (Lerner, 1994) . Patents with a large number of backward citations and claims are more likely to span Empirical test for GTPs multiple technologies. This variable controls for the effect of a patent with backward citations and claims in the same or fewer different industries.
We also controlled for patent assignees of different organizational types. Different organizations have different technological capabilities that will affect the number of different technologies in the backward citations. For example, small start-up firms will focus more narrowly while larger corporations will have operations in diverse application sectors. We constructed three dummy variables for different organizational types: biotechnology firms, universities, and other types of firms. There are 15 patents associated with more than one organizational type: the dummy variables of the organizational types are not mutually exclusive.
We used a dummy variable to identify the effect of Cohen-Boyer patents. This variable is equal to 1, if Cohen-Boyer was the primary patent and equal to 0, if the primary patent was one of the control patents.
Finally, we controlled for yearly variation because the number of different technologies in backward citations can change based on unobservable factors driven by the patent application year. Table 3 provides descriptive statistics. Table 4 provides the correlation matrix. Table 5 provides a set of regressions on the dependent variable testing technological complementarity. We used the negative binomial count data model (NB) because the (2) includes an interaction term of the Cohen-Boyer dummy variable and all inventors located in the Bay area for technological complementarity. The marginal effects of the covariates of Model (2) evaluated at the mean are also provided. Model (1) indicates that complementarity is greater for patents citing CohenBoyer than for patents citing other primary patents (0.28, P50.000). This suggests that patents that cite Cohen-Boyer draw knowledge from a greater number of industry sectors. Moreover, examining the interaction effect between Cohen-Boyer citations and all inventors located in the Bay area in Model (2), the effect on complementarity gets stronger when inventors are located in the Bay area. Thus, greater complementarity was realized when inventors were co-located with inventors of the GPT: the effect is significant (0.93, P50.000). The marginal effect on complementarity of citing Cohen-Boyer technology with all inventors located in the Bay area was 3.27. Evaluating this at the mean value of the independent variables, a patent citing Cohen-Boyer technology cited 0.43 more first-generation patents from different industry sectors than the control patents.
Cohen-Boyer's patent as a GPT: empirical analysis
The effect of the number of domestic backward references on complementarity was positive and significant, while the number of claims was weakly significant. The number of inventors did not have a significant effect on technological complementarity. On the other hand, the number of assignees had a positive and significant Table 5 Empirical results
Independent variables
Technological complementarity
Technological applicability
Model (1) Model (2) Model (3) Model (4) Coef.
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Sig. Sig.: ***1%, **5%, *10%. http://icc.oxfordjournals.org/ effect on technological complementarity, which implies that a GPT is more likely when multiple firms are involved in developing an invention. At the same time, inventions by biotechnology firms had less complementarity than inventions developed by other organizations, suggesting that inventions by biotechnology firms are more likely to be applied narrowly than to a broad array of industry sectors. This implies that biotechnology firms may be focused on relatively more specialized projects that can be profitable in the near future. This issue merits examination with more detailed information about biotechnology firms' research targets. Further descriptive analysis of the technological complementarity associated with Cohen-Boyer indicates that there were 35 industry sectors at the three-digit SIC level and 13 two-digit industry sectors that were complementary to Cohen-Boyer. Cohen-Boyer was most likely to be combined with industries in chemicals (SIC 28), where the overall share was $58.5%. The complementarity between CohenBoyer technology and chemicals declined over time as combinations with other sectors increased. In particular, in the first 3 years 450% of patents citing CohenBoyer were from the fields of chemicals and allied products (SIC 28), especially drug and medicines (SIC 283). However, combinations of the Cohen-Boyer patents with other sectors, such as industrial machinery and equipment (SIC 35) and instruments and allied products (SIC 38), became increasingly more common over time. This is consistent with theory that predicts the GPT diffusion should become broader over time (Bresnahan and Trajtenberg, 1995; Lipsey et al., 2005) .
Model (3) provides the results for technological applicability. The negative binomial model was used because the dependent variable is a non-negative, over dispersed count variable. Model (4) includes the interaction term of citing the CohenBoyer patent and all inventors located in the Bay area, along with the estimates of the marginal effects estimated at the mean of the covariates. We hypothesized (H2) that a patent citing Cohen-Boyer would be associated with a wider variety of industries when compared to patents citing the primary control patents. This captures the horizontal application of a GPT (Bresnahan and Trajtenberg, 1995; Helpman and Trajtenberg, 1998b; Lipsey, 2005) . The positive and statistically significant coefficient indicates that Cohen-Boyer patents yielded greater technological applicability in the second generation of innovation.
In Model (3), applicability is greater for patents citing Cohen-Boyer than for patents citing the three control technologies (1.11, P50.000). This means that patents citing Cohen-Boyer generated innovation in a greater number of industry sectors than patents citing the three control patents. Moreover, examining the interaction effect between citing Cohen-Boyer technology and all the inventors being located in the Bay area, the effect of Cohen-Boyer on applicability became weaker as the number of inventors in the Bay area increased. The overall effect of citing Cohen-Boyer technology and the inventors being located in the Bay area is positive and significant on the applicability, respectively (1.26, P50.000; 0.80, P50.000). This suggests that the Bay area was not the only region that applied Cohen-Boyer technology in a variety of industry sectors.
Evaluating this at the mean value of the independent variables, a patent citing Cohen-Boyer technology cited 0.74 more first-generation patents from different industry sectors than those patents citing other primary technologies. [d(complementarity)/d(Cohen-Boyer) ¼ 0.78 þ (À0.41) Â 0.09]. In summary, our empirical results imply that patents citing Cohen-Boyer were likely to originate in more unique industries than patents citing the three control technologies.
Cross-checking the applicability descriptively, the patents that cite Cohen-Boyer were distributed across 15 industry sectors (based on the USPTO SIC concordance table). The second-generation patents initially appeared in the field of Drug and Medicines (SIC 283). However, as time passed, Cohen-Boyer was applied in other sectors, notably instruments and allied products (SIC 38) and industrial machinery and equipment (SIC 35) .
Location in the Bay area and using Cohen-Boyer's technology had a positive and significant effect on technological complementarity (0.93, P50.000), but no effect on technological applicability. This implies that technologies with wide applications may be invented away from a GPT's origin, although proximity matters for combining different technologies with the GPT. This result suggests that the breadth of innovative capabilities in the region where the GPT-applied technologies are adopted determine the incorporation of GPTs to a variety of industry sectors.
Robustness check on geographic discontinuity
We tested whether patents citing Cohen-Boyer technology were more likely than the control group technologies to be in regions with geographically specialized industry sectors. We constructed location quotients for patents associated with the control patents and tested the difference between the average location quotients of each technology. (See the Appendix Table A1 -A5 for the location quotients of control group technologies). We conducted a two-sample t-test with difference variances for the average location quotients between Cohen-Boyer technology and the control patents. The test results indicate that the Cohen-Boyer technology was more regionally specialized than other GPT candidates.
Next, we estimated a survival analysis to examine the extent to which an inventor located in a GPT's location of origin was more likely to cite that GPT-the discontinuity associated with H3. We used Kaplan and Meier's (1958) non-parametric product limit estimation to compare Bay area inventors to inventors that used Cohen-Boyer technology in another location. The Kaplan-Meier method provides a descriptive view of the overall survival functions, allowing us to unconditionally compare to what extent patents with all inventors in the Bay area and patents with inventors outside the Bay area cite Cohen-Boyer's technology over time (thus serving as a summary statistic). The result indicates that inventors in the Bay area cited Cohen-Boyer's technology more often than inventors in other areas, a result that is consistent with our technological discontinuity hypothesis.
Robustness check on examiner added citations
Thus, far our analyses have included examiner-added citations. One might argue that these citations would lead us to overestimate complementarity and applicability. In this section, we offer analyses that exclude examiner-added citations to check the robustness of our original analyses.
Examiner-added citations can be identified for patents issued since 2001. These citations are marked with an asterisk at the end of the patent number in the citation section of original patent documents issued since 2001. We considered only those patents in the original sample issued in 2001 or later because patents issued before 2001 offer no way to determine which citations were added by examiners. This left us with a sample of 159 patents.
Among those 159 patents, which we call the second-generation patents, 9 had platform patents as examiner-added citations. We excluded those 9 patents, leaving 150 patents for the analyses. We re-constructed the applicability measure using those 150 patents. We also re-constructed the complementarity measure by examineradded prior art. Table 6 presents empirical results for the negative binomial model, excluding examiner-added citations where the dependent variables are the measures of applicability and complementarity and with the same covariates from the original analyses.
The empirical results show that our initial analyses of applicability, complementarity, and discontinuity remain even when examiner-added citations are removed.
Conclusion
This article empirically demonstrates that the Cohen-Boyer innovations are a GPT in terms of technological complementarity and broad technological applicability. This empirical result supports the anecdotal argument that the Cohen-Boyer rDNA technique created important new opportunities for systematically searching large protein molecules, triggering the emergence of the biotechnology industry.
Moreover, inventors located in the Bay area had a positive effect on the CohenBoyer technology by combining it with other technology components in the application sectors. This supports the notion that knowledge spillovers have a strong local component and reinforces the idea that proximity is important to the development of useful applications for new technologies. Proximity may facilitate the intense interaction required to understand the implications of an invention and its potential Empirical test for GTPs applications. Certainly, the Bay area was the locus of creative activity in genetic engineering at the earliest stages of the industry.
The Bay area effect may be a result of characteristics particular to Silicon Valley rather than pure geographic proximity. Silicon Valley is well known as a locus of innovative activity, with significant resources directed toward the exploration of new ideas. For example, Koo (2006) found that the state of California generates the largest count of patents. Kenney and Berg (1999) have argued that Silicon Valley may best be described as a system for creating innovation. While Stanford University's pursuit of the Cohen-Boyer patents was controversial at the time (Feldman et al., 2008) , the university's location in the heart of Silicon Valley undoubtedly contributed to an environment that encouraged the commercialization of the discovery. The potential endogeneity of the discovery is an open question, and follow-on work should examine these effects in greater detail. The testable hypothesis would be that GPTs are more likely to arise from a geographic concentration of inventors than from locations on the periphery of innovative communities. Of course, identifying these technologies is the first step.
The limited boundaries for the Cohen-Boyer technology proved an advantage for our exploratory analysis. This is certainly the first step in a research agenda, and we hope future research will build on the work begun in this article. While we focus on the Cohen-Boyer rDNA patents as a GPT, it is important to consider that technological discoveries are most appropriately considered on a continuum, with incremental discoveries on the lower end, and GPT as the highest and most significant form of discovery. Cohen-Boyer certainly has some of the attributes of a GPT, but additional innovation is usually required for a biotechnology or any GPT to reach its potential, and there are certainly no guarantees in terms of the pace and direction of future development. Lipsey et al. (1998: 50) LQs for the control patents are presented below. An LQ ! 1, bold indicates above average specialization in a sector. Table A5 T-test for difference between the Cohen-Boyer's and control patents location quotients
